References
- VestboJHurdSSAgustiAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
- KocabasAHanciogluATurkyilmazSPrevalence of COPD in Adana, Turkey (BOLD-Turkey Study)Proc Am Thorac Soc20063supplA543
- GunenHHacievliyagilSSYetkinOGulbasGMutluLCPehlivanEPrevalence of COPD: First epidemiological study of a large region in TurkeyEur J Intern Med200819749950419013377
- DeveciFDeveciSETurkogluSThe prevalence of chronic obstructive pulmonary disease in Elazıg, Eastern TurkeyEur J Intern Med201122217217621402248
- Ministry of Health Turkey, Institute of Public Health [homepage on the Internet]Chronic diseases and risk factors survey in Turkey2013 Available from: http://sbu.saglik.gov.tr/Ekutuphane/kitaplar/khrfai.pdfAccessed August 8, 2014
- SchlechtNFSchwartzmanKBourbeauJDyspnea as clinical indicator in patients with chronic obstructive pulmonary diseaseChron Respir Dis20052418319116541601
- VestboJHurdSSRodriguez-RoisinRThe 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)-why and what?Clin Respir J20126420821422906068
- VestboJVogelmeierCSmallMHigginsVUnderstanding the GOLD 2011 Strategy as applied to a real-world COPD populationRespir Med2014108572973624675239
- HanMKMullerovaHCurran-EverettDGOLD 2011 disease severity classification in COPDGene: a prospective cohort studyLancet Respir Med201311435024321803
- BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax199954758158610377201
- JonesPWHardingGBerryPWiklundIChenWHKlineLNDevelopment and first validation of the COPD assessment testEur Respir J200934364865419720809
- BuistASMcBurnieMAVollmerWMInternational variation in the prevalence of COPD (the BOLD Study): a population-based prevalence studyLancet2007370958974175017765523
- NewcombeRGTwo-sided confidence intervals for the single proportion: comparison of seven methodsStat Med19981788578729595616
- SorianoJBAlfagemeIAlmagroPDistribution and prognostic validity of the new Global Initiative for Chronic Obstructive Lung Disease grading classificationChest2013143369470223187891
- CasanovaCMarinJMMartinez-GonzalezCNew GOLD classification: longitudinal data on group assignmentRespir Res201415324417879
- HaughneyJGruffydd-JonesKRobertsJLeeAJHardwellAMcGarveyLThe distribution of COPD in UK general practice using the new GOLD classificationEur Respir J2014434993100224176990
- AgustiAHurdSJonesPFAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohortsEur Respir J20134251391140123645406
- JonesPWNadeauGSmallMAdamekLCharacteristics of a COPD population categorised using the GOLD framework by health status and exacerbationsRespir Med2014108112913524041746
- LangePMarottJLVestboJPrediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classification: a study of the general populationAm J Respir Crit Care Med20121861097598122997207
- NishimuraKOgaTTsukinoMHajiroTIkedaAJonesPWReanalysis of the Japanese experience using the combined COPD assessment of the 2011 GOLD classificationRespir Investig2014522129135
- JochmannANeubauerFMiedingerDSchafrothSTammMLeuppiJDGeneral practitioner’s adherence to the COPD GOLD guidelines: baseline data of the Swiss COPD Cohort StudySwiss Med Wkly Epub2010421
- SeamanJLeonardACPanosRJHealth care utilization history, GOLD guidelines, and respiratory medication prescriptions in patients with COPDInt J Chron Obstruct Pulmon Dis20105899720463890
- FitchKIwasakiKPyensonBPlauschinatCZhangJVariation in adherence with Global Initiative for Chronic Obstructive Lung Disease (GOLD) drug therapy guidelines: a retrospective actuarial claims data analysisCurr Med Res Opin20112771425142921599554